Riggs Asset Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
FLAM
Riggs Asset Management's ANAB Position: Q3 2025 in Review
Riggs Asset Management sold out of AnaptysBio (ANAB) in Q3 2025, closing a stake of 69 shares — an estimated $1.53K sold.
Riggs Asset Management first reported a position in ANAB in Q4 2018 and held it in 27 quarters. The position peaked at $24K in Q3 2020. 166 funds tracked by Wall St. Rank hold ANAB as of Q3 2025.
- Riggs Asset Management reported no remaining AnaptysBio position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 69 AnaptysBio shares in Q3 2025, an estimated $1.53K.
- Riggs Asset Management first reported a position in AnaptysBio in Q4 2018 and held it in 27 quarters.
- Riggs Asset Management's AnaptysBio position peaked at $24K in Q3 2020.
- 166 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.